A new international study led by the Nanobiosystems group at CIC nanoGUNE, is developing miniature, non-invasive, precise robotic catheters for use in reproductive medicine and gynecological health.
NEW YORK and NIJMEGEN, Netherlands, Dec. 1, 2025 /PRNewswire/ — ScreenPoint Medical today announced the completion of a commercial agreement making its Transpara® breast-imaging AI portfolio available through Precision Imaging Network, part of Microsoft for Healthcare. By integrating Transpara with Precision Imaging Network , ScreenPoint Medical expands how healthcare providers can access Breast AI tools to support workflow efficiency and clinical decision-making.
DALLAS, Nov. 30, 2025 /PRNewswire/ — Ikonopedia, a leader in breast imaging reporting and tracking systems, today announced the addition of Contrast-Enhanced Mammography (CEM) to its integrated reporting platform. This expansion enables breast imaging centers to offer patients a powerful diagnostic alternative that improves cancer detection, particularly in women with dense breast tissue. Speak with the Ikonopedia team at RSNA in booth #7803.
Engineers and obstetricians at Monash University have invented a wearable Band-Aid-like patch to track a baby’s movements through the mother’s abdomen, offering a new way to support safer pregnancies from home.
PITTSBURGH , Nov. 25, 2025 /PRNewswire/ — “I thought there should be a way for my wife to get a restful night of sleep while still pumping to maintain the milk supply for feeding our baby,” said an inventor, from Campbellsburg, Ky., “so I invented the AUTO – PUMPING BRA WITH TIIMER FUNCTION. My design helps exhausted moms by eliminating the need to choose between pumping and sleeping.”
Carea, a pregnancy and postnatal wellbeing app that prioritises women’s health, has launched the Postpartum Mum Tracker to support the 1 in 5 new mothers who face post-birth mental health struggles.
A research team led by two University of Maine Ph.D. students developed an artificial intelligence (AI) system that could make it easier and faster for doctors to identify signs of breast cancer in tissue samples, possibly preventing delays and saving lives.
FRANKLIN LAKES, N.J., Nov. 17, 2025 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the Conformité Européenne (CE) Marked BD Onclarity™ HPV Assay for the BD COR™ System and the BD Viper™ LT System have been accepted for the World Health Organization (WHO) list of prequalified in vitro diagnostic products, further expanding access to high-quality cervical cancer screening tools in low- and middle-income countries.
Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for triple-negative breast cancer (TNBC), which is among the most aggressive and difficult-to-treat forms of the disease.
In a move for women’s health, menstrual health startup Joii is launching the world’s first AI-powered app that accurately measures period blood volume in the UK, transforming a guessing game into hard data that benefits patients and clinicians alike.